SK Chemicals Co. has ramped up its production of chemically-recycled (CR) PET for the food container market, made by chemically decomposing waste plastics to turn them into pure raw materials and then used for production.
CR PET uses a chemical recycling technology that depolymerizes waste PET bottles to revert them to a raw material state.
South Korean chemical company stressed that SKYPET CR is free from pollution by foreign substances while ensuring no deterioration of quality.
SK Chemicals is beginning full-scale operation of the mass production system for the CR PET ‘SKYPET CR’ this month.
SK Chemicals has a business agreement with Jeju Province Development Corp., which manufactures bottled water Samdasoo, to jointly develop chemically recycled PET mineral water bottles.
The company also launched the world’s first commercial production of chemically recycled copolyester.


NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Middle East War Rattles Global Markets as Oil Tops $100 and Dollar Surges
Japan Eyes Oil Futures Intervention to Stabilize Yen Amid Middle East Crisis
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure
Bank of Japan Unveils New Inflation Gauge to Support Case for Future Rate Hikes
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Time to buy local: war fuel price shocks reveal the folly of a long food supply chain
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
Iran-Israel Missile Strikes Continue Amid Mixed Signals on U.S.-Iran Diplomacy
Wall Street Slides as Iran War Uncertainty, Oil Surge, and AI Fears Rattle Markets
U.S. Stock Futures Steady as Iran Reviews U.S. Ceasefire Proposal
Oil Prices Plunge Over 6% as Middle East Ceasefire Hopes Ease Supply Fears
Currency Markets Show Caution Amid U.S.-Iran Negotiations
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 



